VRTX News and Press, Vertex Pharmaceuticals Incorporated

2024-07-02 08:58:53 ET Vertex Pharmaceuticals ( NASDAQ: VRTX ) has been granted FDA priority review for its investigational once-daily vanza triple combination treatment for cystic fibrosis, with a target action date set for January 2, 2025.... Read the full article on See...

- Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorization Application (MAA) submission also validated by European Medicines Agency (EMA) Vertex Pharmaceuticals Incorporated (...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2024 financial results on Thursday, August 1, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +...

2024-06-29 11:35:00 ET The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV ), tracking the healthcare companies under S&P 500, rose 0.11% in the second quarter of 2024, lagging behind the broader S&P 500 index which rose 4.30%.... Read the full article on Seeki...

2024-06-28 07:45:00 ET The stock market has its ups and downs -- and if you stay invested for decades, you will likely experience your fair share of both bull and bear markets. At the same time, by investing in a diverse assortment of stocks across various industries, risk profiles, and bus...

2024-06-28 05:50:00 ET Believe it or not, we're nearly halfway through this decade. The healthcare sector could be in store for monumental changes over the next few years. These changes should present great opportunities for investors to make money. But where should they put their money...

2024-06-27 15:21:32 ET Summary bluebird bio, Inc. stock plummeted by 73% amid financial struggles and operational hurdles post FDA approval of their gene therapy Lyfgenia. The company faces intense competition from CRISPR Therapeutics' Casgevy, which benefits from stronger resourc...

2024-06-27 14:02:20 ET More on S&P 500 Index: The Greenback Consolidates While Sustaining A Break Against The Yen Fed Update: The Fed Has A Mortgage-Backed Securities Problem Market Breadth Will Improve As The Soft Landing Comes Into View Nasdaq, S&P,...

2024-06-26 12:31:01 ET Volume away from semiconductor ETFs’ ( SMH ), ( SEMI ), ( NASDAQ: SOXX ) overbought conditions could mean some long-term bullishness with other parts of the market seeing gains, according to an Argus Research Market Movers note.... Read th...

2024-06-25 09:00:00 ET Summary Catalent stock rose 3% after Elevidys label expansion approval by the FDA. Sarepta's stock reached an all-time high after Elevidys label expansion approval. Several companies including PFE, CAPR, RGNX, SLDB, VRTX, have DMD gene-therapy product candid...